The Scientific Advisory Team at Gibson Oncology provides expert guidance and strategic insights for the development and progression of the Indenoisoquinolines. They evaluate clinical trial data, advise on research methodologies, and ensure that the investigational treatments align with the latest scientific advancements and regulatory standards.